• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 14D9/A filed by Vector Group Ltd.

    10/4/24 8:30:25 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $VGR alert in real time by email
    SC 14D9/A 1 d885666dsc14d9a.htm SC 14D9/A SC 14D9/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 14D-9

    Solicitation/Recommendation Statement

    Under Section 14(d)(4) of the Securities Exchange Act of 1934

    (Amendment No. 3)

     

     

    VECTOR GROUP LTD.

    (Name of Subject Company)

     

     

    VECTOR GROUP LTD.

    (Name of Person Filing Statement)

     

     

    Common Stock, $0.10 par value per share

    (Title of Class of Securities)

    92240M108

    (CUSIP Number of Class of Securities)

    Marc N. Bell

    Senior Vice President, General Counsel and Secretary

    Vector Group Ltd.

    4400 Biscayne Boulevard, 10th Floor

    Miami, FL 33137

    (305) 579-8000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications

    on Behalf of the Person Filing Statement)

    With copies to:

    Alison S. Ressler

    Alan J. Fishman

    Sullivan & Cromwell LLP

    125 Broad Street

    New York, New York 10004

    (212) 558-4000

     

     

     

    ☐

    Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

     

     

     


    This Amendment No. 3 (this “Amendment”) to Schedule 14D-9 amends and supplements the Solicitation/Recommendation Statement on Schedule 14D-9 previously filed by Vector Group Ltd., a Delaware corporation (“Vector,” the “Company” or, after the closing of the Transactions, the “Surviving Corporation”), with the Securities and Exchange Commission (the “SEC”) on September 4, 2024 as amended by Amendment No. 1 to the Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on September 18, 2024 and Amendment No. 2 to the Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on September 27, 2024 (as amended, the “Schedule 14D-9”), relating to the tender offer by Vapor Merger Sub Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of JTI (US) Holding Inc., a Delaware corporation (“Parent”), which in turn is an Affiliate of JT International Holding B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) organized and existing under the law of the Netherlands and an Affiliate of Parent (“JTI”), to purchase all of the outstanding shares of Vector’s common stock, par value $0.10 per share (each such share, a “Share” and, collectively, the “Shares”) in exchange for $15.00 per Share in cash, subject to applicable withholding taxes and without interest (the “Offer Price”), on the terms and subject to the conditions set forth in the Offer to Purchase (as it may be amended, supplemented or otherwise modified from time to time, the “Offer to Purchase”) and in the related Letter of Transmittal (as it may be amended, supplemented or otherwise modified from time to time, the “Letter of Transmittal”) and the related Notice of Guaranteed Delivery (as it may be amended, supplemented or otherwise modified from time to time, the “Notice of Guaranteed Delivery”) (which three documents, together with other related materials, collectively constitute the “Offer”). The expiration date of the Offer will be one minute after 11:59 p.m., Eastern time, on October 4, 2024, unless further extended.

    Except as otherwise set forth in this Amendment, the information set forth in the Schedule 14D-9 remains unchanged and is incorporated herein by reference to the extent relevant to the items in this Amendment. Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule 14D-9.

    Item 8. Additional Information

    The subsection of Item 8 of the Schedule 14D-9 entitled “Regulatory Approvals—Antitrust Compliance” is hereby amended as follows:

    The following sentence is added at the end of the second full paragraph as follows:

    “The waiting period applicable to the Offer under the HSR Act expired effective October 3, 2024 at 11:59 p.m., Eastern time.”


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

    VECTOR GROUP LTD.
    By:   /s/ J. Bryant Kirkland III
     

    J. Bryant Kirkland III

     

    Senior Vice President, Treasurer and Chief Financial Officer

    Date: October 4, 2024

    Get the next $VGR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VGR

    DatePrice TargetRatingAnalyst
    3/31/2022$12.00 → $16.00Equal Weight → Overweight
    Barclays
    11/15/2021$13.00 → $17.00Underweight → Equal Weight
    Barclays
    11/9/2021$18.00Perform → Outperform
    Oppenheimer
    9/13/2021$15.00 → $13.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $VGR
    SEC Filings

    View All

    SEC Form 15-12G filed by Vector Group Ltd.

    15-12G - VECTOR GROUP LTD (0000059440) (Filer)

    10/17/24 8:00:07 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form EFFECT filed by Vector Group Ltd.

    EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

    10/8/24 12:15:04 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form EFFECT filed by Vector Group Ltd.

    EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

    10/8/24 12:15:08 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    $VGR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Watkins Barry returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

    4 - VECTOR GROUP LTD (0000059440) (Issuer)

    10/7/24 9:41:06 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Officer Bell Marc N was granted 164,500 shares and returned $5,100,000 worth of shares to the company (340,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

    4 - VECTOR GROUP LTD (0000059440) (Issuer)

    10/7/24 9:14:02 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Sharpe Jean E returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

    4 - VECTOR GROUP LTD (0000059440) (Issuer)

    10/7/24 9:08:43 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    $VGR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hims & Hers Health Set to Join S&P SmallCap 600

    NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

    10/4/24 6:05:00 PM ET
    $HIMS
    $SPGI
    $VGR
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    Vector Group Announces Agreement to be Acquired by JT Group

    Delivers significant value for stockholders while positioning Vector Group for long-term success Vector Group Ltd. (NYSE:VGR) today announced that it has entered into a definitive agreement to be acquired by JT Group, a global company headquartered in Tokyo, Japan, operating in tobacco, pharmaceuticals and processed food. JT Group's global tobacco business, headquartered in Geneva, Switzerland, manufactures and sells some of the world's best-known brands in over 130 markets worldwide – including Winston and Camel (outside the U.S.), as well as MEVIUS and LD. Under the terms of the agreement, JT Group will offer to acquire all outstanding shares of Vector Group common stock for $15.00 pe

    8/21/24 6:00:00 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Group Declares Quarterly Cash Dividend

    Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on September 12, 2024, to holders of record as of August 30, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240819252290/en/

    8/20/24 3:08:00 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    $VGR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vector Grp upgraded by Barclays with a new price target

    Barclays upgraded Vector Grp from Equal Weight to Overweight and set a new price target of $16.00 from $12.00 previously

    3/31/22 7:41:06 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Grp upgraded by Barclays with a new price target

    Barclays upgraded Vector Grp from Underweight to Equal Weight and set a new price target of $17.00 from $13.00 previously

    11/15/21 8:00:05 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Group upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Vector Group from Perform to Outperform and set a new price target of $18.00

    11/9/21 6:13:20 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    $VGR
    Financials

    Live finance-specific insights

    View All

    Vector Group Declares Quarterly Cash Dividend

    Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on September 12, 2024, to holders of record as of August 30, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240819252290/en/

    8/20/24 3:08:00 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Group Reports Second Quarter 2024 Financial Results

    Montego maintains position as largest discount brand in the U.S. Second Quarter 2024 Highlights: Consolidated revenues of $371.9 million, up 1.7% or $6.3 million compared to the prior year period. Tobacco segment wholesale market share increased to 5.7% from 5.4% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period. Montego wholesale and retail market share both increased to 4.1% from 3.4% and 3.5%, respectively, in the prior year period. Operating income of $97.8 million, up 36.5% or $26.1 million compared to the prior year period. Tobacco segment operating income of $102.9 million, up 37.0% or $27.8 million compared to t

    7/31/24 4:45:00 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Group to Host Second Quarter 2024 Results Conference Call

    Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its second quarter 2024 results on Thursday, August 1, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50954. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on August 1, 2024 through August 15, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50954. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.

    7/25/24 8:00:00 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    $VGR
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Health Set to Join S&P SmallCap 600

    NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

    10/4/24 6:05:00 PM ET
    $HIMS
    $SPGI
    $VGR
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    Douglas Elliman Appoints Richard Ferrari as President and CEO of Brokerage for New York City and the Northeast Region

    Yuval Greenblatt and Alfred Renna Promoted to Senior Managing Director of Operations and Senior Managing Director of Sales, Respectively, for Flagship 575 Madison Avenue Office Douglas Elliman, one of the largest residential real estate brokerages in the United States, announced today that real estate veteran Richard Ferrari has joined the firm as President and CEO of Brokerage for New York City and the Northeast Region. In this role, Ferrari, a highly regarded industry expert, will oversee the firm's New York City resale markets, including Manhattan, Brooklyn, Riverdale and Long Island City in Queens. He will also assume responsibility for Elliman's New Jersey, Westchester, Connecticut a

    7/21/21 8:30:00 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Group Appoints Technology Veteran Wilson L. White to its Board of Directors

    Expands Board to 10 Directors with Addition of Silicon Valley Executive Vector Group Ltd. (NYSE:VGR) (the "Company") today announced that it has appointed technology industry veteran, Wilson L. White, to its Board of Directors, effective immediately. Mr. White currently serves as Senior Director of Government Affairs and Public Policy at Google. With Mr. White's appointment, Vector Group's Board expands to 10 directors. "With many years of experience in the technology industry, including government relations and legal expertise, Wilson brings to the Board a unique skillset that will further strengthen Vector Group's commitment to staying at the forefront of our business' rapidly-evolving

    6/22/21 8:00:00 AM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    $VGR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

    SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

    10/15/24 4:00:16 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

    SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

    10/7/24 8:43:24 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

    SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

    10/1/24 4:27:47 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care